Immatics
Home
Inside Immatics
About
Leadership
Board of Directors
Scientific Advisory Board
Collaborations
Locations
Pipeline
UNLOCKING CANCER IMMUNOTHERAPIES
T cells and solid tumors
Technologies
Adoptive Cell Therapies
Next-generation ACT
TCR Bispecifics
Manufacturing
Publications
Patients & Medical Professionals
Clinical Programs
Investors & Media
Overview
Press Releases
Events & Presentations
Stock Information
SEC & Financial Reports
Analyst Coverage
Corporate Governance & Compliance
FAQ
Downloads
Contacts
Working @ Immatics
Working @ Immatics
Jobs
Contact Us
 
Contact Us
search
 
 
Delivering 
the Power of T cells
 to Cancer Patients
READ MORE ABOUT US 
Developing targeted immunotherapies 
with an emphasis 
 on treating solid tumors 
READ MORE HERE 
Advancing our pipeline and product portfolio to  
improve the lives
of cancer patients
READ MORE HERE 
 
Latest NEWS
02 May, 2023 | NewsImmatics Reports Interim Clinical Data from Ongoing Phase 1b Cohort A Monotherapy with ACTengine® IMA203 TCR-T Targeting PRAMEREAD MORE    02 May, 2023 | NewsImmatics Announces First Bristol Myers Squibb Opt-in of TCR-T Candidate from Ongoing Multi-target Strategic CollaborationREAD MORE    21 March, 2023 | NewsImmatics Announces Full Year 2022 Financial Results and Corporate UpdateREAD MORE    
Our PIPELINE INVESTORSOur
 Mission
Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets. This deep know-how is the foundation for our pipeline of Adoptive Cell Therapies and TCR Bispecifics as well as our partnerships with global leaders in the pharmaceutical industry. We are committed to delivering the power of T cells and to unlocking new avenues for patients in their fight against cancer. 
The animation is also available in German - please click here.
Our
 Collaborations
 
 
 Immatics N.V.
Immatics Biotechnologies GmbH
Paul-Ehrlich-Str. 15
72076 Tuebingen
Germany
Phone: +49 7071 5397-0
Fax: +49 7071 5397-900
E-Mail: info@immatics.com
 Immatics US, Inc.
2201 W. Holcombe Blvd.,
Suite 205 Houston, Texas 77030
Business line: +1 346 204-5400
Fax line: +1 346 204-5931
E-Mail: info@immatics.com
 Immatics Biotechnologies GmbH
Machtlfinger Str. 11
81379 Munich
Germany
Phone: +49 89 540415-0
Fax: +49 89 540415-905
E-Mail: info@immatics.com
 
Imprint
Privacy Policy English
Privacy Policy German
 
Cookie Settings
 
 
				© 2023 Immatics N.V.            
×
					Get start  
Leave your contacts and our managers will contact you soon.
Get start
×
 Thank you                
					Your message is successfully sent...                
×
					Sorry                
					Something went wrong                